We are live on
!
Find out more
HCM
Hillman Capital Management Portfolio holdings
AUM
$144M
1-Year Est. Return
7.02%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+7.02%
3 Year Est. Return
+20.27%
5 Year Est. Return
+21.27%
10 Year Est. Return
–
AUM
$291M
AUM Growth
+$6.09M
(+2.1%)
Cap. Flow
+$553K
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
35.69%
Holding
58
New
7
Increased
5
Reduced
42
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$6.43M |
| 2 |
Western Union
WU
|
+$6.22M |
| 3 |
Conagra Brands
CAG
|
+$3.51M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815K |
| 5 |
Air Products & Chemicals
APD
|
+$570K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.59M |
| 2 |
Simon Property Group
SPG
|
+$888K |
| 3 |
Microsoft
MSFT
|
+$850K |
| 4 |
Marriott International
MAR
|
+$591K |
| 5 |
AB InBev
BUD
|
+$529K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Communication Services | 12.83% |
| 3 | Industrials | 11.71% |
| 4 | Energy | 11.58% |
| 5 | Consumer Staples | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares MSCI Emerging Markets ETF
EEM
$30.4B
| $12K | ﹤0.01% |
+250
| New | +$12.6K |
|
52
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $5K | ﹤0.01% |
+44
| New | +$5.25K |
|
53
iShares Russell Mid-Cap Growth ETF
IWP
$21B
| $4K | ﹤0.01% |
+33
| New | +$3.85K |
|
54
iShares Russell 2000 Value ETF
IWN
$14.6B
| $3K | ﹤0.01% |
+17
| New | +$2.83K |
|
55
iShares Core US Aggregate Bond ETF
AGG
$138B
| – | – |
-281
| Closed | -$32K |
|
56
iShares Core S&P Small-Cap ETF
IJR
$112B
| – | – |
-424
| Closed | -$46K |
|
|
57
Marriott International
MAR
$92.5B
| – | – |
-3,990
| Closed | -$591K |
|
|
58
Pfizer
PFE
$150B
| – | – |
-176,532
| Closed | -$7.59M |
|
Similar funds
AL
KK
GGI
I
AGM
PU
TP
12CM
Hillman Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Hillman Capital Management held 58 positions worth $291M, up 2.1% from $285M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Hillman Capital Management's Q4 2021 filing shows 7 new, 5 increased, 42 reduced and 4 closed positions. Its largest new stake was Air Products & Chemicals: 1,943 shares worth $591K. The largest sale was Pfizer, an estimated $7.59M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Communication Services and Industrials.
- Hillman Capital Management's largest Q4 2021 buy was Air Products & Chemicals: 1,943 shares worth $591K.
- Hillman Capital Management added most to Zimmer Biomet in Q4 2021, an estimated $6.43M increase.
- Hillman Capital Management's biggest Q4 2021 reduction was Simon Property Group, cutting an estimated $888K.
- Hillman Capital Management fully exited Pfizer in Q4 2021, selling an estimated $7.59M.
- Hillman Capital Management's ten largest holdings make up 36% of its $291M portfolio in Q4 2021.
- Hillman Capital Management opened 7 new positions and closed 4 in Q4 2021.
- Hillman Capital Management's portfolio value rose 2.1% quarter-over-quarter to $291M.
Based on Hillman Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.